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The patient's oncologic history was notable for papillary thyroid cancer (T1N1a), for which she underwent total thyroidectomy, bilateral paratracheal and superior mediastinal node dissection, and auto transplantation of the left inferior parathyroid into the left trapezius muscle. She declined radioactive iodine therapy because of her desire to conceive. Her past medical history was otherwise negative. She was referred for genetic counseling after the thyroid cancer diagnosis and tested positive for a familial BRCA1 mutation (1793delA). The patient then learned of her cousin's BRCA1 mutation. The geneticist estimated the patient's lifetime risk for bilateral breast cancer at approximately 50% to 80% by age 70 years and risk for ovarian cancer up to 45% by age 70 years.
At an elective surgical consultation, prophylactic bilateral skin sparing mastectomy, nipple sparing mastectomy, and total mastectomy was discussed and compared to continued high risk screening with or without salpingo-oophorectomy which would provide an approximately 50% breast cancer risk reduction. The most recent bilateral digital mammogram and breast MRI with 1.5 Tesla showed no abnormalities.
Physical exam revealed no abnormal lymphadenopathy, skin changes or skin dimpling, no nipple changes or excoriation or discharge, and no palpable breast masses. The patient was not an ideal candidate for nipple sparing mastectomy given grade II ptosis.
Abstract
Prophylactic skin-sparing mastectomy (SSM) and nipple sparing mastectomy (NSM) have become suitable options for breast cancer prevention in appropriate patients with hereditary risk of breast cancer [1] . Prophylactic total mastectomy (TM) provides approximately 90% to 95%-risk reduction in patients with BRCA1 and BRCA 2 mutations [2] . Initially, bilateral TM was recommended because of the concern for an increased breast cancer risk from remaining residual breast tissue. However, studies have demonstrated that SSM and NSM are feasible options for prophylactic surgery in patients with BRCA mutations and provide the opportunity for reconstruction with excellent outcomes [3] [4] [5] . We report a case in which a woman with a BRCA1 mutation underwent prophylactic bilateral SSM and salpingo-Oophorectomy with
Introduction
Paget's disease of the nipple is an uncommon presentation of breast cancer and usually presents with nipple excoriation or ulceration with or without an underlying invasive cancer, but it can be found incidentally on mastectomy specimens performed for invasive cancer [6] [7] [8] . We report a case of a 35 year old woman with a BRCA 1 mutation who was found to have incidental Paget's disease of the nipple without an underlying invasive or in situ carcinoma component from a prophylactic skin-sparing mastectomy. 
Case Report

Discussion
To our knowledge, this case is unique in finding incidental Paget's disease of the nipple on a prophylactic skin sparing mastectomy for BRCA mutation. Increased genetic testing in unaffected women who pursue prophylactic mastectomy may lead to more detection of incidental malignancies even in the era of breast MRI screening. Patients undergoing nipple sparing mastectomy who also have increased risk of breast cancer should be aware of the chance, albeit small, of future malignancy involving the nipple. Several studies report a low incidence of nipple related abnormalities during prophylactic mastectomy. Eisenberg et al. reviewed 117 patients who underwent prophylactic NSM and showed no histologic abnormality or malignancy in any of the nipple margins [9] . Other series have examined the histologic findings in mastectomy After consultation with plastic surgery, the patient elected to have bilateral skin-sparing mastectomy with immediate tissue expander reconstruction combined with bilateral salpingo-oophorectomy by the gynecologist. The patient did well after surgery with no complications and had final reconstruction with bilateral silicone implants.
Pathology
On pathologic evaluation, both breasts showed no evidence of invasive or in situ cancer or any high risk proliferative lesions. However, the left nipple showed focal atypical cells in the nipple. The differential included toker cells, an atypical melanocytic proliferation, and Paget's disease. The left breast was extensively sampled, revealing no underlying malignancy. Immunohistochemical staining was performed on sections of the nipple which showed atypical cells in the epidermis with positive staining for cytokeratin 7, estrogen and melanomas can arise in the areola but melanomas of the nipple proper are exceedingly rare. Although the histopathologic distinction might be problematic, immunohistochemical markers specific to melanoma such as HMB-45, Melan-A will help to establish the diagnosis ( Table  1 ).
The treatment for clinically diagnosed Paget's disease in the absence of pre-operative evidence of underlying malignancy involves either a total mastectomy or breast conserving therapy (resection of the nipple areolar complex followed by whole-breast radiation) [7, 14] . There are two pathologic theories describing the origin of Paget's disease of the breast: in situ versus epidermotropic [22] . If the origin is thought to be in situ malignant transformation, originating in the nipple epithelium, then local resection of the nipple-areolar complex followed by irradiation is sufficient treatment. However, if Paget's cells originate from ductal cancer cells that have migrated along the basal membrane of the nipple, then mastectomy is necessary. Systemic treatment is determined by the presence of an underlying malignancy.
Nipple sparing mastectomy has become an increasingly utilized technique for appropriate breast cancer patients and those at high risk for breast cancer with low incidence of future recurrences [23] . In a retrospective review of 23 BRCA positive patients who underwent prophylactic NSM, in situ cancer was incidentally found in one patient and there were no local recurrences after a mean of 51 months [22] . Another study examined the nipple areolar complex from therapeutic and prophylactic mastectomy specimens of BRCA carriers, finding no incidental disease in any of the 33 prophylactic specimens [24] . Although uncommon, the incidental pathologic finding of Paget's disease in the nipple raises the importance of continued clinical follow up in high risk patients who increasingly undergo nipple sparing mastectomy.
specimens from patients with hereditary risk factors or BRCA mutations. One series showed an odds ratio of 12.7 for the detection of any high-risk lesion (ductal carcinoma in situ, lobular carcinoma in situ, atypical ductal hyperplasia, or atypical lobular hyperplasia) in specimens from BRCA mutation carriers [10] . Another series of 67 women found 57% had an atypical finding within the prophylactic mastectomy specimen: 37% atypical lobular hyperplasia, 39% atypical ductal hyperplasia, 25% lobular carcinoma-in-situ, and 15% ductal carcinoma-in-situ. The presence of high-risk lesions was independently related to age over 40 years (odds ratio 6.6), and inversely related to bilateral oophorectomy before prophylactic mastectomy (odds ratio 0.2) [11] . None of these series reported any significant findings within the nipple. Patients with a clinically negative exam and no detectable malignancy in the mastectomy specimen have an extremely low likelihood of having significant disease within the nipple.
Paget's disease refers to a clinical diagnosis characterized by a scaly, ulcerated, and raw appearance to the nipple. Paget's disease of the breast was first described by Sir James Paget in 1874, when he published his findings of 15 women with ulceration of the nipple followed by cancer of the mammary gland. The overall incidence of Paget's disease is low among women with breast disease, ranging from 1-4.5% [12, 13] . The majority of patients (85-88%) with Paget's disease of the nipple have an underlying invasive malignancy, and in 25% of cases there is no clinical or radiographic evidence of the occult tumor [14] [15] [16] [17] . However, most of these studies were done prior to routine use of breast MRI screening.
Historically, Paget's disease is thought to be an epidermotropic carcinoma. In most cases, there is an invasive or in situ carcinoma in the underlying breast parenchyma and tumor cells originating in breast ducts migrate to nipple epidermis either by through duct system or direct invasion. In the majority of cases an underlying carcinoma is identified. However, there are rare Paget's disease cases in which no underlying carcinoma is identified despite extensive sampling [18] 
